Science and Research

Human alveolar epithelial cells type II are capable of TGFbeta-dependent epithelial-mesenchymal-transition and collagen-synthesis

BACKGROUND: The origin of collagen-producing cells in lung fibrosis is unclear. The involvement of embryonic signaling pathways has been acknowledged and trans-differentiation of epithelial cells is discussed critically. The work presented here investigates the role of TGFB in cytoskeleton remodeling and the expression of Epithelial-Mesenchymal-Transition markers by Alveolar Epithelial Cells Type II and tests the hypothesis if human alveolar epithelial cells are capable of trans-differentiation and production of pro-fibrotic collagen. METHODS: Primary human alveolar epithelial cells type II were extracted from donor tissues and stimulated with TGFbeta and a TGFbeta-inhibitor. Transcriptome and pathway analyses as well as validation of results on protein level were conducted. RESULTS: A TGFbeta-responsive fingerprint was found and investigated for mutual interactions. Interaction modules exhibited enrichment of genes that favor actin cytoskeleton remodeling, differentiation processes and collagen metabolism. Cross-validation of the TGFbeta-responsive fingerprint in an independent IPF dataset revealed overlap of genes and supported the direction of regulated genes and TGFbeta-specificity. CONCLUSIONS: Primary human alveolar epithelial cells type II seem undergo a TGFbeta-dependent phenotypic change, exhibit differential expression of EMT markers in vitro and acquire the potential to produce collagen.

  • Goldmann, T.
  • Zissel, G.
  • Watz, H.
  • Dromann, D.
  • Reck, M.
  • Kugler, C.
  • Rabe, K. F.
  • Marwitz, S.

Keywords

  • Aged
  • Alveolar Epithelial Cells/drug effects/*metabolism
  • Cells, Cultured
  • Collagen/*biosynthesis
  • Epithelial-Mesenchymal Transition/drug effects/*physiology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Transforming Growth Factor beta/*pharmacology
  • *Alveolar epithelial cells
  • *Collagen
  • *emt
  • *Fibrosis
Publication details
DOI: 10.1186/s12931-018-0841-9
Journal: Respiratory research
Pages: 138 
Number: 1
Work Type: Original
Location: Assoziierter Partner, ARCN
Disease Area: COPD
Partner / Member: FZB, Ghd, UKSH (Lübeck)
Access-Number: 30041633
See publication on PubMed

DZL Engagements

chevron-down